Antimalarial effects of rifampin in Plasmodium vivax malaria.

The antimalarial effects of rifampin in 60 adults with Plasmodium vivax malaria were assessed. There were three treatment groups: rifampin (20 and 15 mg/kg of body weight per day for 1 and 4 days, respectively; n = 5); rifampin followed by primaquine (15 mg of base per day for 14 days; n = 25), and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Pukrittayakamee, S, Viravan, C, Charoenlarp, P, Yeamput, C, Wilson, R J, White, N J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 1994
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284489/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203846/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.511
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller